A Bourne1, D Reid1, F Hickson1, S Torres-Rueda2, P Weatherburn1. 1. Sigma Research, Department of Social & Environmental Health Research, London School of Hygiene & Tropical Medicine, London, UK. 2. Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.
Abstract
BACKGROUND: 'Chemsex' is a colloquial term used in the UK that describes sex under the influence of psychoactive substances (typically crystal methamphetamine, mephedrone and gamma-hydroxybutyric acid (GHB)/gamma-butyrolactone (GBL)). Recently, concern has been raised as to the impact of such behaviour on HIV/sexually transmitted infection (STI) transmission risk behaviour, which this qualitative study aimed to explore via semistructured interviews with gay men living in three South London boroughs. METHODS: Interviews were conducted with 30 community-recruited gay men (age range 21-53) who lived in the boroughs of Lambeth, Southwark and Lewisham, and who had used crystal methamphetamine, mephedrone or GHB/GBL either immediately before or during sex with another man during the previous 12 months. Data were subjected to a thematic analysis. RESULTS: Chemsex typically featured more partners and a longer duration than other forms of sex, and the relationship between drug use and HIV/STI transmission risk behaviour was varied. While some men believed that engaging in chemsex had unwittingly led them to take risks, others maintained strict personal rules about having safer sex. Among many participants with diagnosed HIV, there was little evidence that the use of drugs had significantly influenced their engagement in condomless anal intercourse (primarily with other men believed to be HIV positive), but their use had facilitated sex with more men and for longer. CONCLUSIONS: Analysis revealed that, within this sample, chemsex is never less risky than sex without drugs, and is sometimes more so. Targeted clinic-based and community-based harm reduction and sexual health interventions are required to address the prevention needs of gay men combining psychoactive substances with sex. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: 'Chemsex' is a colloquial term used in the UK that describes sex under the influence of psychoactive substances (typically crystal methamphetamine, mephedrone and gamma-hydroxybutyric acid (GHB)/gamma-butyrolactone (GBL)). Recently, concern has been raised as to the impact of such behaviour on HIV/sexually transmitted infection (STI) transmission risk behaviour, which this qualitative study aimed to explore via semistructured interviews with gay men living in three South London boroughs. METHODS: Interviews were conducted with 30 community-recruited gay men (age range 21-53) who lived in the boroughs of Lambeth, Southwark and Lewisham, and who had used crystal methamphetamine, mephedrone or GHB/GBL either immediately before or during sex with another man during the previous 12 months. Data were subjected to a thematic analysis. RESULTS: Chemsex typically featured more partners and a longer duration than other forms of sex, and the relationship between drug use and HIV/STI transmission risk behaviour was varied. While some men believed that engaging in chemsex had unwittingly led them to take risks, others maintained strict personal rules about having safer sex. Among many participants with diagnosed HIV, there was little evidence that the use of drugs had significantly influenced their engagement in condomless anal intercourse (primarily with other men believed to be HIV positive), but their use had facilitated sex with more men and for longer. CONCLUSIONS: Analysis revealed that, within this sample, chemsex is never less risky than sex without drugs, and is sometimes more so. Targeted clinic-based and community-based harm reduction and sexual health interventions are required to address the prevention needs of gay men combining psychoactive substances with sex. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
DRUG MISUSE; GAY MEN; HEALTH PROMOTION; QUALITATIVE RESEARCH; SEXUAL BEHAVIOUR
Authors: Adam W Carrico; Walter Gόmez; Jennifer Jain; Steven Shoptaw; Michael V Discepola; David Olem; Justin Lagana-Jackson; Rick Andrews; Torsten B Neilands; Samantha E Dilworth; Jennifer L Evans; William J Woods; Judith T Moskowitz Journal: Drug Alcohol Depend Date: 2018-09-05 Impact factor: 4.492
Authors: Natalie Thurtle; Rachelle Abouchedid; John R H Archer; James Ho; Takahiro Yamamoto; Paul I Dargan; David M Wood Journal: J Med Toxicol Date: 2016-09-06
Authors: Morgan M Philbin; Emily R Greene; Silvia S Martins; Natalie J LaBossier; Pia M Mauro Journal: Am J Prev Med Date: 2020-09-24 Impact factor: 5.043
Authors: Melanie Stecher; Martin Hoenigl; Anna Maria Eis-Hübinger; Clara Lehmann; Gerd Fätkenheuer; Jan-Christian Wasmuth; Elena Knops; Jörg Janne Vehreschild; Sanjay Mehta; Antoine Chaillon Journal: Clin Infect Dis Date: 2019-04-24 Impact factor: 9.079
Authors: Sharful Islam Khan; Mohammad Niaz Morshed Khan; Samira Dishti Irfan; A M Rumayan Hasan; Allen G Ross; Lily Ming-Sha Horng; Nathan Lachowsky; Gail Knudson; Tasnim Azim Journal: Arch Sex Behav Date: 2020-04-01